<- Back to digest

JSES - 2026-11-01 - Journal Article

Pre-operative proton pump inhibitor use and risk of adverse outcomes after total elbow arthroplasty: a propensity-matched analysis.

Frappa N, Dillon MR, Fuller SI, Divasta A, Gamsarian V, Alben MG

retrospective cohortLOE IIIn = 1,629–1,646 per matched cohortUp to 10 years (time-to-event with censoring at last clinical activity)

Topics

shoulder elbowtraumaarthroplasty
PMID: 42191059DOI: 10.1016/j.jse.2026.05.010View on PubMed ->

Key Takeaway

Preoperative PPI use was associated with a 2.6-fold increased hazard of revision TEA and 2.19-fold increased hazard of mechanical loosening at 5 years compared to non-users after propensity matching.

Summary Depth

Choose how much analysis to show on this article page.

Summary

This propensity-matched retrospective cohort study using the TriNetX database examined whether preoperative PPI use within 6 months of primary TEA was associated with increased complication rates. At 1 year, PPI users had significantly higher revision (RR 1.74, HR 1.87) and PJI rates (RR 1.72, HR 1.81), with no significant difference at 90 days. At 5 and 10 years, PPI exposure was independently associated with increased hazards of revision, PJI, mechanical loosening, periprosthetic fracture, and VTE, with HRs ranging from 1.68 to 2.60.

Key Limitation

The database design prevents determination of whether PPI use is a direct causal risk factor or a surrogate for unmeasured comorbidity burden not fully captured by propensity matching.

Original Abstract

BACKGROUND

Proton pump inhibitors (PPIs) are widely prescribed and commonly used in orthopedic patients, yet increasing evidence links chronic PPI exposure to infectious, skeletal, and thromboembolic complications. While associations have been reported following hip, knee, and spine surgery, the impact of PPI use on outcomes after total elbow arthroplasty (TEA) remains poorly characterized.

METHODS

We performed a retrospective propensity-matched cohort study using the TriNetX Global Collaborative Network. Adult patients undergoing primary TEA were stratified by pre-operative PPI exposure within 6 months of surgery. One-to-one propensity score matching was conducted on demographic variables and relevant comorbidities. Outcomes included revision TEA, periprosthetic joint infection (PJI), mechanical loosening, periprosthetic fracture, venous thromboembolism (VTE), and mortality assessed at 90 days and 1 year and within 5-year and 10-year analysis windows using time-to-event methods with censoring at last recorded clinical activity. Risk ratios (RRs) and hazard ratios (HRs) were calculated using Kaplan-Meier survival analyses and Cox proportional hazards models.

RESULTS

After matching, cohorts were well balanced (n = 1,629-1,646 per cohort). Early (90-day) outcomes did not differ significantly between groups. By 1 year, PPI users demonstrated higher rates of revision surgery (RR: 1.74; HR: 1.87) and PJI (RR: 1.72; HR: 1.81). Within the 5-year and 10-year analysis windows, PPI exposure was associated with increased hazards of revision TEA (HR: 2.60 and 2.39), PJI (HR: 1.68 and 1.78), mechanical loosening (HR: 2.19 and 2.25), periprosthetic fracture (HR: 1.84 and 2.14), and VTE (HR: 2.08 and 1.93).

CONCLUSION

Pre-operative PPI exposure was associated with higher risks of implant-related complications and VTE following TEA, with divergence emerging after the early post-operative period and persisting at long-term follow-up. These findings suggest that PPI use may represent a marker of elevated risk in patients undergoing TEA and may be relevant to pre-operative optimization and post-operative surveillance among chronic PPI users. Prospective studies are needed to clarify causality and distinguish the effects of pre-operative vs. post-operative PPI exposure.